Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Liangge Powder Decoction (Liang Ge San) is a traditional Chinese medicinal formula used to treat upper and middle burner heat syndromes. In the context of modern clinical practice, it is being investigated for its efficacy in treating sepsis-associated acute gastrointestinal injury (AGI). The formula typically consists of Forsythiae Fructus, Rhei Radix et Rhizoma, Natrii Sulfas, Glycyrrhizae Radix et Rhizoma, Gardeniae Fructus, Menthae Haplocalycis Herba, Scutellariae Radix, and Lophatheri Herba. Its mechanism involves clearing heat, detoxifying, and promoting bowel movements, which translates to anti-inflammatory effects, reduction of systemic inflammatory response syndrome (SIRS), and protection of the intestinal mucosal barrier.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on liangge powder decoction.